Price Alert

Rohto Pharmaceutical Co.L... (RPHCF)

PNK: RPHCF · Real-Time Price · USD

20.09

-6.54 (-24.56%)

At close: Jan 24, 2025, 9:00 PM

Rohto Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash & Equivalents	89.21B	580.26M	515.09M	540.94M	584.78M	591.93M	525.63M	568.91M	582.48M	585.46M	625.15M	525.66M	472.9M	49.2B	47.06B	44.42B
Short-Term Investments	n/a	n/a	15.86M	n/a	17.01M	n/a	14.65M	n/a	15.49M	n/a	n/a	n/a	6.42M	n/a	n/a	n/a
Long-Term Investments	n/a	292.09M	270.2M	262.4M	253.19M	228.45M	198.74M	215.99M	231.1M	239.72M	261.08M	248.01M	267.76M	n/a	n/a	n/a
Other Long-Term Assets	49.72B	65.4M	61.23M	60.34M	-9.45B	74.67M	71.38M	78.64M	-9.43B	89.07M	88.81M	96.1M	-25.46M	31.45B	31.84B	31.41B
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	46.66B	343.69M	325.13M	322.53M	309.07M	331.09M	293.37M	294.57M	275.42M	301.81M	291.69M	277.32M	252.71M	33.64B	34.2B	33.21B
Other Current Assets	78.89B	83.82B	79.82B	71.5B	69.23B	73.59B	64.99B	60.43B	57.99B	55.73B	53.23B	45.96B	52.18B	45.67B	48.16B	44.44B
Total Current Assets	214.76B	1.52B	1.39B	1.36B	1.43B	1.48B	1.28B	1.31B	1.35B	1.37B	1.4B	1.22B	1.2B	128.51B	129.41B	122.07B
Property-Plant & Equipment	68.61B	484.69M	457.44M	461.97M	498.15M	516.66M	468.03M	487.31M	516.22M	521.17M	538.29M	465.83M	450.59M	49.45B	48.58B	47.98B
Goodwill & Intangibles	9.22B	9.13B	9.33B	9.47B	9.56B	9.65B	9.81B	9.29B	9.54B	9.32B	7.32B	7.45B	104.52M	5.82B	4.95B	5.02B
Total Long-Term Assets	131.41B	906.88M	851.31M	850.31M	898.96M	893.36M	805.93M	850.36M	906.29M	930.96M	953.92M	877.05M	839.09M	86.71B	85.37B	84.42B
Total Assets	346.18B	2.42B	2.24B	2.21B	2.33B	2.38B	2.09B	2.16B	2.26B	2.3B	2.35B	2.09B	2.04B	215.23B	214.79B	206.49B
Account Payables	16.99B	18.31B	18.61B	20.18B	16.02B	17.8B	17.3B	18.12B	13.66B	15.63B	14.37B	13.54B	9.6B	12.44B	12.44B	12.51B
Deferred Revenue	n/a	40.99M	37.01M	26.65M	38M	40.45M	32.78M	28.93M	25.11M	40.95M	41.58M	20.2M	44.78M	26.81B	29.27B	27.59B
Short-Term Debt	5.3B	4.36B	4.17B	4.16B	4.18B	4.71B	5.85B	8.04B	8.03B	7.45B	5.49B	2.93B	2.31B	2.34B	2.57B	2.46B
Other Current Liabilities	58.15B	-27.86B	-27.75B	-27.64B	-25.83B	-27.2B	-27.36B	-29.52B	-24.29B	41.99B	-23.81B	38.48B	38.42B	35.81B	37.97B	37.29B
Total Current Liabilities	87.09B	592.71M	555.21M	548.27M	603.38M	609.48M	538.43M	576.73M	587.27M	606.16M	671.31M	515.38M	511.05M	53.31B	55.73B	54.05B
Long-Term Debt	5.19B	5.27B	5.82B	6.94B	7.52B	10.99B	11.53B	12.76B	13.35B	12.98B	9.33B	7.11B	5.79B	6.33B	6.67B	5.22B
Other Long-Term Liabilities	2.68B	-5.18B	-5.73B	-6.85B	-8.58B	-10.85B	-11.4B	-12.61B	-14.73B	4.89B	-9.2B	-6.99B	-6.67B	7.81B	8.08B	7.95B
Total Long-Term Liabilities	12.05B	88.68M	88.27M	95.11M	108.64M	140.56M	129.55M	147.23M	158.58M	155.23M	127.27M	126.67M	114.98M	14.15B	14.75B	13.18B
Total Liabilities	99.14B	681.39M	643.48M	643.38M	712.02M	750.03M	667.98M	723.95M	745.86M	761.39M	798.58M	642.05M	626.03M	67.45B	70.48B	67.22B
Total Debt	10.49B	68.26M	66.88M	76.94M	102.46M	119.72M	120.07M	153.19M	178.44M	177.51M	133.11M	90.53M	76.82M	8.68B	9.25B	7.69B
Common Stock	6.5B	46.09M	43.52M	45.06M	48.96M	49.59M	44.92M	47.9M	53.43M	56.49M	58.43M	58.6M	58.86M	6.5B	6.5B	6.5B
Retained Earnings	209.4B	1.45B	1.32B	1.32B	1.39B	1.37B	1.2B	1.23B	1.33B	1.37B	1.38B	1.33B	1.32B	140.06B	136.68B	132.44B
Comprehensive Income	n/a	202.4M	189.3M	160.37M	140.79M	165.07M	139.2M	110.32M	71.76M	51.68M	50.4M	50.18M	65.42M	n/a	n/a	n/a
Shareholders Equity	246.32B	1.7B	1.56B	1.53B	1.58B	1.58B	1.38B	1.39B	1.46B	1.49B	1.5B	1.45B	1.41B	147.11B	143.64B	138.61B
Total Investments	44.34B	292.09M	286.06M	262.4M	270.2M	228.45M	213.39M	215.99M	246.6M	239.72M	261.08M	248.01M	274.17M	24.59B	24.62B	24.16B